STOCK TITAN

Gregory George beneficial owner at Mesoblast (OTC: MEOBF) with 22.36% stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Mesoblast Ltd Amendment reports that Gregory George beneficially owns 288,522,256 ordinary shares, representing 22.36% of the class as of March 6, 2026, based on 1,290,302,187 ordinary shares outstanding as of March 6, 2025.

The filing breaks down holdings: Gregory George directly holds 138,723,887 shares (including 10,430,602 warrants and 128,293,285 ADRs) and reports shared voting/dispositive power over additional shares held by G to the Fourth Investments, LLC (135,798,292) and by his sons James George (8,000,000) and Grant George (6,000,000). The filing lists James George with 8,000,000 shares (0.62%), Grant George with 6,000,000 shares (0.47%), and G to the Fourth Investments, LLC with 135,798,292 shares (10.52%).

Positive

  • None.

Negative

  • None.

Insights

Large concentrated ownership and family control are clearly disclosed.

The filing shows a single individual, Gregory George, with direct and attributed holdings totaling 288,522,256 shares (22.36%) as of March 6, 2026. This combines direct holdings, warrants, ADRs, and shares held via a related LLC.

Such concentration gives the reporting persons meaningful voting influence; subsequent proxy materials or related-party disclosures in future filings could clarify governance actions tied to this ownership.

Schedule 13G/A amendment properly attributes derivative and affiliated holdings.

The amendment specifies beneficial ownership calculations and cites 1,290,302,187 ordinary shares outstanding as the denominator (as of March 6, 2025. It also discloses 10,430,602 warrants counted within Gregory George's total.

Filing mechanics and attribution to related parties (G to the Fourth Investments, LLC, and family members) are explicit; any future change in voting/dispositive authority would require additional amendments.






03/06/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



George, Gregory
Signature:/s/ Gregory George
Name/Title:Gregory George
Date:03/11/2026
JAMES GEORGE
Signature:/s/ James George
Name/Title:James George
Date:03/11/2026
GRANT GEORGE
Signature:/s/ Grant George
Name/Title:Grant George
Date:03/11/2026
G to the Fourth Investments, LLC
Signature:/s/ Gregory George
Name/Title:Gregory George, Manager
Date:03/11/2026

FAQ

What stake does Gregory George report in Mesoblast (MEOBF)?

Gregory George reports beneficial ownership of 288,522,256 shares, equal to 22.36% of the class. This figure is based on 1,290,302,187 ordinary shares outstanding as of March 6, 2025 and is stated in the amendment filed on March 11, 2026.

How much does G to the Fourth Investments, LLC own in Mesoblast?

G to the Fourth Investments, LLC is reported to hold 135,798,292 shares, representing 10.52% of the class. The amendment attributes shared voting and dispositive power over these shares to Gregory George as manager.

Do the reported holdings include warrants or ADRs?

Yes. Gregory George's reported direct holdings include 10,430,602 ordinary shares underlying warrants and 128,293,285 ordinary shares held as ADRs, both disclosed in the ownership breakdown in Item 4.

What percentages do James and Grant George hold individually?

James George is reported to beneficially own 8,000,000 shares (0.62%) and Grant George 6,000,000 shares (0.47%). The filing also notes Gregory George has discretionary authority over those ADR holdings.

What vote/dispositive powers are disclosed for Gregory George?

The amendment discloses Gregory George with 138,723,887 sole voting and dispositive power and 149,798,292 shared voting and dispositive power, reflecting direct holdings plus shares attributable through related parties and warrants.
Mesoblast

OTC:MEOBF

View MEOBF Stock Overview

MEOBF Rankings

MEOBF Latest SEC Filings

MEOBF Stock Data

2.06B
819.25M
Biotechnology
Healthcare
Link
Australia
Melbourne